Published 11 hours ago
Submitted by Biogen
WASHINGTON, February 5, 2021 /CSRwire/ – Arcadia, a monthly subscription service that connects renters and homeowners across the US to wind and solar energy through their utility accounts, today announced a new partnership with Biogen, a pioneer in neuroscience, that will offer all US-based Biogen employees access to 100% renewable energy in their homes. Biogen is covering Arcadia membership costs for US-based employees, adding a new benefit that advances its Healthy Climate, Healthy LivesTM initiative, a commitment to meaningfully engage its employees in its efforts to go fossil fuel free and improve public health. Arcadia’s renewable energy offering is a key component of the employee engagement goals for this initiative, through which Biogen became the first Fortune 500 company committing to become fossil fuel free across its operations by 2040.
In markets where regulation allows, such as Massachusetts, where Biogen is headquartered, employees can further increase their impact by signing up for community solar through Arcadia. Community solar lets customers route a portion of their energy bill to support a local solar farm.
Millions of American employees are using electricity at home rather than in the office. Arcadia’s residential energy data shows an average 2% increase in energy usage and a 6% increase in electricity bills for households in 2020. Due to limited mobility in the pandemic, home electricity use has become the greatest contributor to climate change for many employees. Arcadia is working with businesses such as Biogen to get employees easy access to renewable energy and community solar to reduce their environmental impact.
“It’s never been a more important time to fight for a renewable energy future and take action against climate change,” said Alexa Minerva, Senior Director of Partnerships at Arcadia. “Companies are paying more attention to their corporate sustainability goals and making climate-conscious decisions. It’s great to see Biogen leverage Arcadia’s platform to do good for its employees and the planet.”
“We are excited to collaborate with Arcadia and enable employees to make the switch to 100% renewable electricity at home”, said Nicole Murphy, Senior Vice President of Global Manufacturing and Technical Operations at Biogen. “In 2014 we achieved carbon neutrality through our commitment to purchase 100% of our electricity from renewable sources. Now, as part of Healthy Climate, Healthy Lives, we want to further address our Scope 3 emissions. By creating opportunities for our employees to engage and advance our goals for climate, health and equity we aim to be a catalyst for positive change globally and reduce their impact.”
For Biogen employees participating in the company’s Renewable Electricity Opt-in Program, Biogen will cover the cost premium of purchasing 100% renewable electricity. The company has a goal to have all employees participate in this program by 2030 to help transition towards a world without fossil fuels. US-based employees have the option to participate in the Arcadia subscription program, while those in the US and international locations that have already signed up to a 100% renewable electricity contract with their home energy supplier can receive a fixed annual reimbursement of $200 USD. For employees that cannot enroll in renewable electricity programs due to regulatory restrictions, who do not pay their electricity, or that want an alternative to the fixed annual reimbursement, Biogen will purchase and retire 11 megawatt-hours of renewable energy credits, an amount equal to the average household usage.
About Arcadia renewable energy benefits
- Arcadia connects companies in any state with 100% clean energy for their employees’ homes. Companies can also choose to subsidize monthly electric bills for their teams through the platform.
- If employees live in Colorado, Illinois, Maine, Maryland, Massachusetts, New York, or Rhode Island, they can sign up for community solar. This lets them route a portion of their energy bill to support a local solar farm. In doing so, they’re not just connecting their home to clean energy, they’re also adding more clean energy to their local grid.
- Employees have access to their own Arcadia account for their home. An account takes two minutes to set up, streamlines utility bill payments, and lets employees track their clean energy impact.
- Businesses have access to sustainability reports that can be used in their scope 3 emissions reporting.
Scope 3 emissions, also referred to as “value chain emissions,” come from activities that aren’t directly controlled by a company but that are still connected to it, such as transportation of goods and travel. Scope 3 emissions make up the largest source of greenhouse gas emissions for many companies. With employees working from home and traveling less, companies interested in managing their carbon emissions should be exploring strategies to reduce emissions from home energy use.
For more information on Arcadia’s employee benefits program and ways you can partner with Arcadia, please visit www.arcadia.com/partners.
Arcadia gives customers a simple, easy, and affordable way to choose renewable energy, connecting their home and community to the highest standards of clean energy. Founded in 2014, Arcadia integrates with 125 utilities in all 50 states, manages 4.5 terawatt-hours of residential energy demand, and is the largest manager of residential community solar subscribers in the US. Join us in achieving our vision of a 100% renewable energy future at www.arcadia.com.
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
More from Biogen